Aveanna Healthcare Holdings Inc.

NASDAQ:AVAH

Medical - Care Facilities

Healthcare
$10.85 +1.33%

+$0.10 today

Market cap
$2.37B
Beta
1.93
P/E (TTM)
6.3
EPS (TTM)
$1.22
52W Low $3.73High $10.32

Volume 2.12M

Average 1.52M

AVAH EBITDA Margin

EBITDA as a percentage of revenue.

Aveanna Healthcare Holdings Inc.NASDAQ: AVAH

EBITDA Margin · Q3 FY2026 · quarter ended Oct 2026

EBITDA Margin widens to 13.7%

EBITDA Margin was 13.7% in Q3 FY2026, up 4.7 pp from a year earlier. On a trailing-twelve-month basis it was 13.0%, up 1.4 pp year over year. Over 3 fiscal years it widened by 40.8 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 7 analysts of 14.8% for the fiscal year ending Jan 2027, up from 11.5% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterOct 2026
13.7%-0.0 pp QoQ
Last fiscal yearJan 2026
11.5%+2.2 pp YoY
LTMOct 2026
13.0%+1.4 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+4.7 pp+2.1 pp-2.6 pp
1 year+2.2 pp+3.4 pp+1.2 pp
3 years+40.8 pp+3.5 pp-37.3 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
11.5%
Year-over-year change
+2.2pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How AVAH compares with its peers on the latest reported figures

  • AVAH's LTM Oct 2026 EBITDA Margin of 13.0% is the 4th highest of the 7 companies compared; the peer median is 14.0%.
  • Its year-over-year change of +1.4 pp is the highest of 7, against a peer median of +0.1 pp.
  • Over three fiscal years its change of +40.8 pp compares with a peer median of +1.6 pp.
AVAH Competitors Peer median
EBITDA Margin for AVAH and competitors
Company Period LTM level YoY 3-year change
EHCEncompass Health CorporationLTM Jun 202624.2% +1.1 pp+3.6 pp
VMDViemed Healthcare, Inc.LTM Mar 202618.5% +0.7 pp+1.2 pp
CHEChemed CorporationLTM Jun 202616.6% -1.4 pp-1.7 pp
AVAHAveanna Healthcare Holdings Inc.LTM Oct 202613.0% +1.4 pp+40.8 pp
ADUSAddus HomeCare CorporationLTM Jun 202611.3% +0.7 pp+2.0 pp
OPCHOption Care Health, Inc.LTM Sep 20266.9% -0.5 pp-0.9 pp
PNTGThe Pennant Group, Inc.LTM Mar 20265.9% -0.7 pp+2.7 pp
Peer median (excluding AVAH) 14.0%+0.1 pp+1.6 pp

Competitors are the stored peer set for AVAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Jan 2026
Revenue1.68B1.79B1.9B2.02B2.43B
Cost of Revenue1.14B1.23B1.3B1.39B1.63B
Gross Profit542.4M553.23M595.43M635.54M805.15M
Gross Margin32.3%30.9%31.4%31.4%33.1%
Research & Development00000
Selling, General & Admin419.64M483.95M464.74M470.47M526.74M
Operating Expenses578.52M1.2B587.36M495.76M539.77M
Depreciation & Amortization35.39M38.82M30.1M31.16M28.22M
EBITDA(17.96M)(525.06M)39.17M187.38M279.02M
EBITDA Margin-1.1%-29.4%2.1%9.3%11.5%
Operating Income(36.11M)(642.28M)8.07M139.79M265.38M
Operating Margin-2.2%-35.9%0.4%6.9%10.9%
Interest Income253K679K327K498K2.83M
Interest Expense68.93M107.72M153.25M156.6M140.09M
Other Income / Expenses(77.47M)(21.54M)(147.07M)(134.72M)(158.43M)
Income Before Tax(113.58M)(663.81M)(139M)5.07M106.95M
Pre-Tax Margin-6.8%-37.1%-7.3%0.3%4.4%
Income Tax Expense3.47M(1.78M)(4.47M)16M(118.09M)
Net Income(117.04M)(662.03M)(134.52M)(10.93M)225.03M
Net Margin-7.0%-37.0%-7.1%-0.5%9.2%
EPS (Basic)(0.63)(3.57)(0.71)(0.06)1.10
EPS (Diluted)(0.63)(3.57)(0.71)(0.06)1.05
Weighted Avg Shares184.73M185.55M189.96M192.89M203.53M
Weighted Avg Shares (Diluted)184.73M185.55M189.96M192.89M214.98M

Aveanna Healthcare Holdings Inc.

NASDAQ:AVAH

Intrinsic Alpha fair value

Locked

Current Price

$10.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.